Singh akanchha (42 risultati)

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Paperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.

Condizione: New.

Condizione: New.

Condizione: New.

Paperback. Condizione: Brand New. 295 pages. 11.00x8.25x11.02 inches. In Stock.

Taschenbuch. Condizione: Neu. Immunotherapy in Oral Squamous Cell Carcinoma | Immunotherapy in OSCC | Akanchha Singh (u. a.) | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786208438500 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Condizione: Neu. IMMUNOTHERAPY IN ORAL SQUAMOUS CELL CARCINOMA | RECENT ADVANCES AND TECHNIQUES | Akanchha Singh (u. a.) | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786205632413 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Condizione: As New. Unread book in perfect condition.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New. Dr. Akanchha Singh - Assistant Professor at Manav Rachna University, holds a Ph.D. from Khwaja Moinuddin Chishti Language University, Lucknow. With over six years of academic experience, she specializes in Human Resource Management and Organizatio.

Condizione: New.

Buch. Condizione: Neu. Neuware - Artificial Intelligence (AI) has transcended its origins as a computational discipline to become a transformative force across nearly every domain of human endeavour. From boardrooms to courtrooms, classrooms to clinics, AI is reshaping how decisions are made, how knowledge is transferred, and how societies evolve. This book, Artificial Intelligence and New Age Technology: Exploring Innovations, Challenges, and Sustainable Business Landscapes, is a multidisciplinary exploration of AI's innovations, its challenges, and the sustainable pathways it must follow to serve humanity responsibly. As we transition from Industry 4.0 to the more human-centric vision of Industry 5.0, the integration of intelligent technologies with ethical, inclusive, and sustainable values becomes paramount. AI offers immense potential to enhance decision-making, automate complex processes, and personalize experiences. Yet, its rapid adoption also raises pressing questions around accountability, privacy, equity and governance.…

PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 108 pp. Englisch.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 108 pp. Englisch.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Immunotherapy has emerged as a promising treatment modality for oral squamous cell carcinoma (OSCC), especially in advanced and recurrent cases where conventional therapies offer limited survival benefits. By harnessing the body's immune system, immunotherapeutic approaches such as immune checkpoint inhibitors-particularly anti-PD-1 agents like nivolumab and pembrolizumab-have shown improved overall survival and quality of life in select OSCC patients, as demonstrated in landmark trials like KEYNOTE-048 and CheckMate 141. Other strategies, including cancer vaccines, adoptive cell therapy, cytokine therapy, and oncolytic viruses, are under investigation but have yet to achieve widespread clinical use. Despite these advances, challenges such as low response rates, immune-related adverse events, tumor heterogeneity, and resistance mechanisms limit the efficacy of immunotherapy. Biomarkers like PD-L1 expression, tumor mutational burden, and immune gene signatures are being explored to guide patient selection and predict response. Combination therapies with chemotherapy, radiotherapy, or other immunomodulators are being developed to enhance outcomes. …

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Immunotherapy has emerged as a promising modality in the treatment of Oral Squamous Cell Carcinoma (OSCC), particularly for advanced and recurrent cases. Unlike conventional therapies, which target the tumor directly, immunotherapy harnesses the body's immune system to recognize and destroy cancer cells. The most widely studied approach in OSCC involves immune checkpoint inhibitors targeting the PD-1/PD-L1 axis. Drugs like nivolumab and pembrolizumab have demonstrated improved survival rates in patients with recurrent or metastatic OSCC, especially those with PD-L1 expression.Combining immunotherapy with surgery, radiotherapy, or chemotherapy is being explored to increase efficacy. As research progresses, personalized immunotherapy guided by molecular profiling holds the potential to significantly improve prognosis and quality of life for OSCC patients. Continuous clinical trials and translational research are critical to overcoming current limitations and expanding its therapeutic role.…